Matthew M Logan

Title: The Innovations of Matthew M Logan

Introduction

Matthew M Logan is an accomplished inventor based in Brooklyn, MI (US). He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on batrachotoxin analogues. His research focuses on compounds that modulate sodium channel activity, which has important implications for medical treatments.

Latest Patents

Matthew M Logan holds a patent for "Batrachotoxin analogues, compositions, uses, and preparation thereof." This patent includes compounds related to batrachotoxin, specifically analogs that can modulate the activity of sodium channels. The pharmaceutical compositions he developed include vehicles that enhance transdermal permeation of the compounds. These innovations are particularly useful in treating conditions that require reduced neuronal activity or muscular relaxation. Additionally, the compounds are beneficial for patients suffering from voltage-gated sodium channel-enhanced ailments or pain.

Career Highlights

Matthew M Logan is affiliated with Leland Stanford Junior University, where he continues to advance his research in pharmacology and medicinal chemistry. His work has garnered attention for its potential applications in various therapeutic areas.

Collaborations

Matthew has collaborated with notable colleagues, including Justin Du Bois and Abigail Sloan Devlin. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Matthew M Logan's contributions to the field of pharmaceutical sciences through his patent on batrachotoxin analogues highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to improve patient care through innovative treatments.